Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hope for hepatitis b? early trial of Tune-401 begins

NCT ID NCT06671093

Recruiting now Disease control Sponsor: Tune Therapeutics, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage study tests the safety of a new drug, Tune-401, in 36 adults with chronic hepatitis B. Participants must already be on standard antiviral medication. The goal is to see if Tune-401 is safe and how the body processes it, not yet to cure the infection.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS B are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic hepatitis B virus infection hepatitis hepatitis B virus infection Hepatitis, Chronic

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC HEP B CHRONIC HEPATITIS CHRONIC HEPATITIS B HBV

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • New Zealand Clinical Research

    RECRUITING

    Auckland, 1010, New Zealand

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • PMSI Republican Clinical Hospital "Timofei Mosneaga", Arensia Exploratory Medicine Phase I Unit

    RECRUITING

    Chisinau, MD2025, Moldova

    Contact

  • Queen Mary Hospital, University of Hong Kong

    RECRUITING

    Hong Kong, Hong Kong

    Contact

    Contact